Lucid Genomics joins Compatibility Partnership with Oxford Nanopore Technologies

Lucid Genomics is funded by the European Regional Development Fund

Berlin, 24.03.2025

We are proud to announce that Lucid Genomics is funded by the European Regional Development Fund (EFRE) supported through the Investitionsbank Berlin (IBB).

Project name

Development of deep learning technologies for accurate detection of large structural variants

Project description
With the ProFIT project, Lucid Genomics will further develop deep learning technologies for the accurate detection and analysis of structural variants in short-read whole-genome sequencing data. Short-read sequencing is currently only able to accurately detect single nucleotide variants. Other technologies such as long-read sequencing are too expensive to be used substantially. The AI-Framework that will be developed will enable different types of users to use their data more extensively.

FIND YOUR SOLUTION

Cut through the noise.
Get to the answer.

Whether you're making diagnostic decisions or pushing the boundaries of discovery, Lucid meets you where the data gets complex.

FOR CLINICIANS

Diagnose with confidence.

Explore solutions

FOR RESEARCHERS

Investigate with confidence.

Explore solutions